| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
CGMPReceptor (GC A)CAMPNitric oxide NONHERFNHERF1NHERF2PDZK1IKEPPcGKII| 1 | 2000 | Guanylyl cyclases and signaling by cyclic GMP. | 
| + | - | nl | Pharmacol Rev 52(3):375-414 (2000) |
| 2 | 2010 | cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action. | 
| + | - | nl | Pharmacol Rev 62(3):525-63 (2010) Francis SH |
| 3 | 2005 | The biology of cyclic GMP-dependent protein kinases. | 
| + | - | nl | J Biol Chem 280(1):1-4 (2005) Hofmann F |
| 4 | 2003 | Regulation of gene expression by cyclic GMP. | 
| + | - | nl | Circ Res 93(11):1034-46 (2003) Pilz RB |
| 5 | 2003 | Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. | 
| + | - | nl | Circ Res 93(10):907-16 (2003) Feil R |
| 6 | 2003 | Cyclic GMP phosphodiesterases and regulation of smooth muscle function. | 
| + | - | nl | Circ Res 93(4):280-91 (2003) Rybalkin SD |
| 7 | 2003 | Regulation of nitric oxide-sensitive guanylyl cyclase. | 
| + | - | nl | Circ Res 93(2):96-105 (2003) Friebe A |
| 8 | 2003 | Structure, regulation, and function of mammalian membrane guanylyl cyclase receptors, with a focus on guanylyl cyclase-A. | 
| + | - | nl | Circ Res 93(8):700-9 (2003) |
| 9 | 2007 | cAMP and cGMP signaling cross-talk: role of phosphodiesterases and implications for cardiac pathophysiology. | 
| + | - | nl | Circ Res 100(11):1569-78 (2007) |
| 10 | 2007 | Phosphodiesterase regulation of nitric oxide signaling. | 
| + | - | nl | Cardiovasc Res 75(2):303-14 (2007) |
| 11 | 2005 | NHERF family and NHE3 regulation. | 
| + | - | nl | J Physiol 567(Pt 1):3-11 (2005) |